Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells

被引:23
作者
Tang, T
Arbiser, JL
Brandt, SJ
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[4] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN 37232 USA
[5] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M109812200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The basic helix-loop-helix transcription factor TAL1 (or SCL), originally identified from its involvement by a chromosomal rearrangement in T-cell acute lymphoblastic leukemia, is required for hematopoietic development. TAL1 also has a critical role in embryonic vascular remodeling and is expressed in endothelial cells postnatally, although little is known about its function or regulation in this cell type. We report here that the important proangiogenic stimulus hypoxia stimulates phosphorylation, ubiquitination, and proteasomal breakdown of TAL1 in endothelial cells. Tryptic phosphopeptide mapping and chemical inhibitor studies showed that hypoxia induced the mitogen-activated protein kinase-mediated phosphorylation of a single serine residue, Ser(122), in the protein, and site-directed mutagenesis demonstrated that Ser(122) phosphorylation was necessary for hypoxic acceleration of TAL1 turnover in an immortalized murine endothelial cell line. Finally, whereas TAL1 expression was detected in endothelial cells from both large and small vessels, hypoxia-induced TAL1 turnover was observed only in microvascular endothelial cells. Besides their implications for TAL1 function in angiogenic processes, these results demonstrate that a protein kinase(s) important for mitogenic signaling is also utilized in hypoxic endothelial cells to target a transcription factor for destruction.
引用
收藏
页码:18365 / 18372
页数:8
相关论文
共 86 条
[21]   GROWTH-FACTOR EFFECTS ON CELLS OF THE VASCULAR WALL - A SURVEY [J].
DAMORE, PA ;
SMITH, SR .
GROWTH FACTORS, 1993, 8 (01) :61-75
[22]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[23]  
DOYLE K, 1994, J BIOL CHEM, V269, P12099
[24]   TAL1/SCL is expressed in endothelial progenitor cells angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis [J].
Drake, CJ ;
Brandt, SJ ;
Trusk, TC ;
Little, CD .
DEVELOPMENTAL BIOLOGY, 1997, 192 (01) :17-30
[25]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689
[26]  
ELLEDGE SJ, 1998, BIOCHIM BIOPHYS ACTA, V1377, P61
[27]  
Elwood NJ, 1998, BLOOD, V91, P3756
[28]   Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles [J].
Gavine, PR ;
Neil, JC ;
Crouch, DH .
ONCOGENE, 1999, 18 (52) :7552-7558
[29]   The SCL gene specifies haemangioblast development from early mesoderm [J].
Gering, M ;
Rodaway, ARF ;
Göttgens, B ;
Patient, RK ;
Green, AR .
EMBO JOURNAL, 1998, 17 (14) :4029-4045
[30]  
GOLDFARB AN, 1992, BLOOD, V80, P2858